Capillary Blood Collection Devices Market - By Product Type (Micro-container Tube, Micro-hematocrit Tube, Warming Device, Lancing Device), Application (Glucose Monitoring, Hematocrit, Cholesterol Testing), Material, End-use-Global Forecast, 2024-2032

Description

Capillary Blood Collection Devices Market is expected to grow at a rate of 7.7% during 2024-2032, driven by rising prevalence of chronic diseases, growing emphasis on point-of-care testing (POCT), and expansion of home healthcare.

The steady rise in chronic conditions such as diabetes, cardiovascular diseases, and cancer necessitates frequent monitoring and diagnostic testing. According to WHO, each year, noncommunicable diseases (NCDs) claim 41 million lives, accounting for 74% of all global deaths. Of these, 17 million occur prematurely, with 86% of these early deaths concentrated in low- and middle-income countries. Capillary blood collection devices facilitate diagnosis by enabling healthcare providers to collect blood samples quickly and efficiently, particularly in point-of-care testing (POCT) settings and home healthcare environments. As the aging population grows and preventive healthcare initiatives gain traction, the demand for these devices for diagnostic testing and monitoring purposes is expected to increase, driving market expansion.

Capillary Blood Collection Devices Market is classified based on product type, application, material, end-use, and region.

Warming device segment is expected to witness a demand surge by 2032, as they facilitate the collection of capillary blood samples by gently heating the targeted area, thereby increasing blood flow and minimizing discomfort for patients. These devices are beneficial in cold environments or when dealing with pediatric or elderly patients, where obtaining a sufficient blood sample can be challenging. Additionally, warming devices help preserve the quality of the collected sample, reducing the risk of clotting and ensuring accurate test results.

Glass material segment is poised to gain traction through 2032. Glass offers superior clarity, enabling precise visual inspection of blood samples and facilitating accurate analysis. Moreover, glass tubes are chemically inert, ensuring the integrity of the collected sample by preventing interactions with the tube material. This makes glass a preferred material for capillary blood collection devices, particularly in laboratory settings where sample quality is paramount.

Asia Pacific capillary blood collection devices industry share will enlarge over 2024 to 2032, driven by rapidly expanding healthcare infrastructure, coupled with the rising prevalence of chronic diseases. Countries such as China, India, and Japan are witnessing increased investments in healthcare, fueling the demand for capillary blood collection devices. Moreover, the growing awareness about preventive healthcare measures and the rising adoption of point-of-care testing contribute to market expansion in the region.

Product Code: 8035

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic diseases
  - 3.2.1.2 Growing emphasis on point-of-care testing (POCT)
  - 3.2.1.3 Technological advancements and product innovations
  - 3.2.1.4 Rise in home healthcare and self-monitoring
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Limited blood volume for testing
  - 3.2.2.2 Concerns regarding pain and discomfort
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Micro-container tubes
5.3 Micro-hematocrit tubes
5.4 Warming devices
5.5 Lancing devices
- 5.5.1 Adjustable lancing devices
- 5.5.2 Non-adjustable lancing devices
5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Material, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Plastic
6.3 Glass
6.4 Other materials

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Glucose monitoring
7.3 Hematocrit testing
7.4 Cholesterol testing
7.5 Coagulation testing
7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals and clinics
8.3 Blood banks
8.4 Diagnostic centers
8.5 Home diagnosis
8.6 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

10.1 Abbott Laboratories
10.2 Becton, Dickinson and Company
10.3 Cardinal Health
10.4 Greiner Bio-One International GmbH
10.5 Medtronic plc
10.6 Radiometer Medical ApS
10.7 Roche Diagnostics
10.8 Sarstedt AG & Co.
10.9 Siemens Healthineers
10.10 Terumo Corporation